Kainos Group plc CORRECTION: Director/PDMR Shareholding (2472W)
10 December 2019 - 1:37AM
UK Regulatory
TIDMKNOS
RNS Number : 2472W
Kainos Group plc
09 December 2019
09 December 2019
Kainos Group plc
("Kainos" or the "Company")
Corrected Announcement
Further to the announcement of 6 December 2019 at 15.29 under
RNS number 1006W which discloses the number of Ordinary Shares held
by Paul Gannon, Director, stated an incorrect number of Ordinary
Shares. The correct number of Ordinary Shares held by Paul Gannon
and his PCAs is 8,045,508, constituting 6.62% of the issued share
capital of the Company.
The Holding(s) in Company announcement released on 6 December at
15.29 under RNS number 1009W was therefore released in error.
All other details remain unchanged. The corrected announcement
is set out below.
Director / PDMR shareholdings
The Company was notified on 6 December 2019 that Paul Gannon,
Director, has exercised his 2016 PSP options over 45,923 Ordinary
Shares of GBP0.005 in the Company ("Ordinary Shares"), at an
exercise price of GBP0.005 per Ordinary Share.
Following this notification, Paul Gannon and his PCAs have a
reportable shareholding of 8,045,508 Ordinary Shares in the issued
share capital of the Company, constituting 6.62% of the issued
share capital of the Company.
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name Paul Gannon
------------------------------ ---------------------------------
2. Reason for the notification
-----------------------------------------------------------------
a. Position/status Director
------------------------------ ---------------------------------
b. Initial notification Initial
/Amendment
------------------------------ ---------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------
a. Name Kainos Group plc
------------------------------ ---------------------------------
b. LEI 213800H2PQMIF3OVZY47
------------------------------ ---------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------
a. Description of Ordinary Shares of GBP0.005 each
the
Financial instrument/
type of instrument KNOS
Identification
code
------------------------------ ---------------------------------
b. Nature of the transaction Exercise of Options
------------------------------ ---------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
0.5p 45923
------------------------------ ---------------------------------
d. Aggregated information
* Aggregated volume N/A
* Price
------------------------------ ---------------------------------
e. Date of the transaction 06-12-2019
------------------------------ ---------------------------------
f. Place of the transaction LSE - Regulated Market - XLON
------------------------------ ---------------------------------
Kainos Group plc Legal Entity Identifier:
213800H2PQMIF3OVZY47
Ends
For further information, please contact:
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Investec Bank plc +44 20 7597 5970
Patrick Robb / Sebastian Lawrence
Canaccord Genuity Limited +44 20 7523 4606
Simon Bridges/ Andrew Potts
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Kwaku Aning / Leah Dudley
About Kainos
Kainos Group plc is a UK-headquartered provider of Digital
Services and Digital Platforms.
The Group's Digital Services include full lifecycle development
and support of customised Digital Services for government and
commercial customers. Kainos is also the leading European partner
for Workday, Inc. ('Workday'), responsible for implementing
Workday's innovative Software-as-a-Service (SaaS) platform for
enterprise and, now, government customers.
The Group's Digital Platforms comprise specialised digital
platforms in the mobile healthcare and automated testing arenas.
Smart is an automated testing platform for Workday customers;
Evolve Electronic Medical Records ('EMR') is the market-leading
product for the digitisation of patient notes in the Acute sector
of the NHS.
Kainos has over 1,550 people across 12 offices in Europe and
North America.
Kainos is listed on the London Stock Exchange (LSE: KNOS). For
further information, please visit www.kainos.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLLFVSFELAIIA
(END) Dow Jones Newswires
December 09, 2019 09:37 ET (14:37 GMT)
Kainos (LSE:KNOS)
Historical Stock Chart
From Apr 2024 to May 2024
Kainos (LSE:KNOS)
Historical Stock Chart
From May 2023 to May 2024